295 related articles for article (PubMed ID: 26970080)
21. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
Vemuri VK; Janero DR; Makriyannis A
Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
[TBL] [Abstract][Full Text] [Related]
22. [The modulatory role of endocannabinoids in sleep].
Murillo-Rodríguez E
Rev Neurol; 2008 Feb 1-15; 46(3):160-6. PubMed ID: 18297624
[TBL] [Abstract][Full Text] [Related]
23. Role of cannabinoids in the development of fatty liver (steatosis).
Purohit V; Rapaka R; Shurtleff D
AAPS J; 2010 Jun; 12(2):233-7. PubMed ID: 20204561
[TBL] [Abstract][Full Text] [Related]
24. The endocannabinoid system: emotion, learning and addiction.
Moreira FA; Lutz B
Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
[TBL] [Abstract][Full Text] [Related]
25. Role of endocannabinoids and cannabinoid CB1 receptors in alcohol-related behaviors.
Hungund BL; Basavarajappa BS
Ann N Y Acad Sci; 2004 Oct; 1025():515-27. PubMed ID: 15542757
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex.
Urbanski MJ; Kovacs FE; Szabo B
Neuroscience; 2010 Sep; 169(3):1268-78. PubMed ID: 20553815
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
Di Marzo V; Piscitelli F; Mechoulam R
Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
[TBL] [Abstract][Full Text] [Related]
28. The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
.
Di Marzo V
Dialogues Clin Neurosci; 2020 Sep; 22(3):259-269. PubMed ID: 33162769
[TBL] [Abstract][Full Text] [Related]
29. [Functional role of the endocannabinoid system in emotional homeostasis].
Marco EM; Viveros MP
Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
[TBL] [Abstract][Full Text] [Related]
30. Are Type 1 metabotropic glutamate receptors a viable therapeutic target for the treatment of cerebellar ataxia?
Power EM; English NA; Empson RM
J Physiol; 2016 Aug; 594(16):4643-52. PubMed ID: 26748626
[TBL] [Abstract][Full Text] [Related]
31. The endocannabinoid system and gut-brain signalling.
Storr MA; Sharkey KA
Curr Opin Pharmacol; 2007 Dec; 7(6):575-82. PubMed ID: 17904903
[TBL] [Abstract][Full Text] [Related]
32. Presynaptic modulation by endocannabinoids.
Lovinger DM
Handb Exp Pharmacol; 2008; (184):435-77. PubMed ID: 18064422
[TBL] [Abstract][Full Text] [Related]
33. Proinflammatory activation of microglia in the cerebellum hyperexcites Purkinje cells to trigger ataxia.
Xie ST; Fan WC; Zhao XS; Ma XY; Li ZL; Zhao YR; Yang F; Shi Y; Rong H; Cui ZS; Chen JY; Li HZ; Yan C; Zhang Q; Wang JJ; Zhang XY; Gu XP; Ma ZL; Zhu JN
Pharmacol Res; 2023 May; 191():106773. PubMed ID: 37068531
[TBL] [Abstract][Full Text] [Related]
34. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
[TBL] [Abstract][Full Text] [Related]
35. Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids.
Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
Acta Biol Hung; 2007; 58 Suppl():113-29. PubMed ID: 18297798
[TBL] [Abstract][Full Text] [Related]
36. The endocannabinoid system and its therapeutic exploitation.
Di Marzo V; Bifulco M; De Petrocellis L
Nat Rev Drug Discov; 2004 Sep; 3(9):771-84. PubMed ID: 15340387
[TBL] [Abstract][Full Text] [Related]
37. The role of the CB1 receptor in the regulation of sleep.
Murillo-Rodríguez E
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1420-7. PubMed ID: 18514375
[TBL] [Abstract][Full Text] [Related]
38. An Introduction to the Endogenous Cannabinoid System.
Lu HC; Mackie K
Biol Psychiatry; 2016 Apr; 79(7):516-25. PubMed ID: 26698193
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoids modulate the P-type high-voltage-activated calcium currents in purkinje neurons.
Fisyunov A; Tsintsadze V; Min R; Burnashev N; Lozovaya N
J Neurophysiol; 2006 Sep; 96(3):1267-77. PubMed ID: 16738209
[TBL] [Abstract][Full Text] [Related]
40. CB1 cannabinoid receptor-mediated anandamide signaling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy.
Medeiros P; de Freitas RL; Silva MO; Coimbra NC; Melo-Thomas L
Neuroscience; 2016 Nov; 337():17-26. PubMed ID: 27595886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
